Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts
โ Scribed by Peracchi, M. ;Bamonti-Catena, F. ;Bareggi, B. ;Calori, R. ;Maiolo, A. T.
- Publisher
- Springer-Verlag
- Year
- 1990
- Weight
- 387 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Myelodysplastic syndromes (MDS) are heterogeneous diseases. Patients with blast counts of more than 20% of nucleated bone marrow cells have a high risk of short survival. We treated six patients with refractory anemia with excess of blast in transformation (RAEBiT) with low dose cytosine arabinoside
The WHO classification subdivides the FAB RAEB category into RAEB-1 (bone marrow (BM) blasts <10%, peripheral blasts <5%) and RAEB-2 (bone marrow blasts >10% and peripheral blasts >5%). We reclassified according to WHO criteria 228 RAEB patients and analysed them in terms of haematological, karyotyp